HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans-Jörg Martin Selected Research

Hans-Jörg Martin Research Topics

Disease

7Neoplasms (Cancer)
02/2022 - 03/2006
2Cardiotoxicity
05/2019 - 06/2015
1Carcinogenesis
11/2018
1Colorectal Neoplasms (Colorectal Cancer)
07/2009
1Heart Failure
10/2008
1Glioma (Gliomas)
08/2008
1Astrocytoma (Pilocytic Astrocytoma)
08/2008

Drug/Important Bio-Agent (IBA)

3Daunorubicin (Cerubidine)FDA LinkGeneric
02/2022 - 06/2015
2Cytostatic AgentsIBA
02/2022 - 03/2006
2XenobioticsIBA
02/2022 - 03/2006
2daunorubicinolIBA
05/2019 - 06/2015
2Aldo-Keto ReductasesIBA
11/2018 - 07/2009
1EnzymesIBA
02/2022
1FlavonoidsIBA
05/2019
1AnthracyclinesIBA
06/2015
1CurcuminIBA
06/2015
1AntioxidantsIBA
06/2015
1Oxidoreductases (Dehydrogenase)IBA
06/2015
1DiarylheptanoidsIBA
06/2015
1oracineIBA
10/2009
1Bortezomib (Velcade)FDA Link
07/2009
1Proteasome InhibitorsIBA
07/2009
1UbiquitinIBA
07/2009
1Proteasome Endopeptidase Complex (Proteasome)IBA
07/2009
1Antineoplastic Agents (Antineoplastics)IBA
10/2008
1alpha-TocopherolFDA Link
08/2008
1tert-ButylhydroperoxideIBA
08/2008
1PeroxidesIBA
08/2008
1cumene hydroperoxideIBA
08/2008
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
08/2008

Therapy/Procedure

1Aftercare (After-Treatment)
07/2009